Cheryl R. Blanchard
Overview
Cheryl R. Blanchard received an average of $7M in total compensation, including $608K in salary, at Anika Therapeutics between 2020 and 2021. Cheryl Blanchard also received an average of $2M at Zimmer Biomet Holdings between 2008 and 2009.
Source: SEC filings on April 27, 2022, April 30, 2021, and March 19, 2010.
Related executives
We found 36 more executives who work or worked at Anika Therapeutics and Zimmer Biomet Holdings.
Bryan Hanson
Zimmer Biomet Holdings
Chief Executive Officer
Ivan Tornos
Zimmer Biomet Holdings
Chief Operating Officer
Suketu Upadhyay
Zimmer Biomet Holdings
Chief Financial Officer
Wilfred van Zuilen
Zimmer Biomet Holdings
President, EMEA
Sang Yi
Zimmer Biomet Holdings
President, APAC
Michael Levitz
Anika Therapeutics
Chief Financial Officer
David Colleran
Anika Therapeutics
General Counsel
Thomas Finnerty
Anika Therapeutics